Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Dendritic cell therapy has emerged as a promising alternative for treating various forms of cancer, particularly in ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

The wife of a beloved Peacehaven barber says her husband would not be alive today if it was not for the “incredible” support of the community ...

HC Wainwright reaffirmed their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research note released on Friday,Benzinga reports. HC Wainwright currently has a ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.